It has been demonstrated that demethylation of the SOST promoter by 5-aza-2′-deoxycytidine (AzadC) induces a strong increase in SOST expression in MG63 osteosarcoma cell line, presumably by facilitating the binding of transcription factors to the proximal promoter [16]. The gene discussed is SOST; the disease is osteosarcoma.